<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kozar I</submitter><funding>Fond National de la Recherche (FNR)</funding><funding>NCI NIH HHS</funding><funding>Fond National de la Recherche</funding><pagination>1096</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7961530</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(5)</volume><pubmed_abstract>MicroRNAs are key post-transcriptional gene regulators often displaying aberrant expression patterns in cancer. As microRNAs are promising disease-associated biomarkers and modulators of responsiveness to anti-cancer therapies, a solid understanding of their targetome is crucial. Despite enormous research efforts, the success rates of available tools to reliably predict microRNAs (miRNA)-target interactions remains limited. To investigate the disease-associated miRNA targetome, we have applied modified cross-linking ligation and sequencing of hybrids (qCLASH) to BRAF-mutant melanoma cells. The resulting RNA-RNA hybrid molecules provide a comprehensive and unbiased snapshot of direct miRNA-target interactions. The regulatory effects on selected miRNA target genes in predicted vs. non-predic</pubmed_abstract><journal>Cancers</journal><pubmed_title>Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.</pubmed_title><pmcid>PMC7961530</pmcid><funding_grant_id>P01 CA214091</funding_grant_id><funding_grant_id>PRIDE15/10675146/CANBIO</funding_grant_id><pubmed_authors>Gay LA</pubmed_authors><pubmed_authors>Kozar I</pubmed_authors><pubmed_authors>Philippidou D</pubmed_authors><pubmed_authors>Kreis S</pubmed_authors><pubmed_authors>Margue C</pubmed_authors><pubmed_authors>Renne R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.</name><description>MicroRNAs are key post-transcriptional gene regulators often displaying aberrant expression patterns in cancer. As microRNAs are promising disease-associated biomarkers and modulators of responsiveness to anti-cancer therapies, a solid understanding of their targetome is crucial. Despite enormous research efforts, the success rates of available tools to reliably predict microRNAs (miRNA)-target interactions remains limited. To investigate the disease-associated miRNA targetome, we have applied modified cross-linking ligation and sequencing of hybrids (qCLASH) to BRAF-mutant melanoma cells. The resulting RNA-RNA hybrid molecules provide a comprehensive and unbiased snapshot of direct miRNA-target interactions. The regulatory effects on selected miRNA target genes in predicted vs. non-predic</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-22T10:48:39.711Z</modification><creation>2022-02-09T12:41:21.718Z</creation></dates><accession>S-EPMC7961530</accession><cross_references><pubmed>33806450</pubmed><doi>10.3390/cancers13051096</doi></cross_references></HashMap>